Skip to main content
. 2018 Jan 9;79(5):437–444. doi: 10.1055/s-0037-1615816

Fig. 1.

Fig. 1

Treatment strategy. The main treatment strategies for the two groups are displayed. RMS, rhabdomyosarcoma; VDC, vincristine, dactinomycin, and cyclophosphamide; ES, Ewing sarcoma; VDC/IE, vincristine, doxorubicin and cyclophosphamide/ifosfamide and etoposide; RT, radiotherapy.